Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Premature hair graying is common and linked to stress, obesity, vitamin deficiencies, family history, lack of exercise, smoking, and allergies.

Arsenic exposure from contaminated water severely damages the skin, causing hair loss, pigmentation changes, irritation, and can lead to skin cancer.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

Androgenetic alopecia is linked to factors like age, family hair loss history, diet, and health conditions.

The bio-based complex effectively repairs and protects chemically damaged hair.

Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Interval training is better for heart and metabolic health in reproductive-aged females than regular moderate exercise.

Moxibustion may help improve ovarian function by changing androgen levels.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Goat hair shows changes in metal levels and stress when goats move from indoors to mountain pastures.

Chromosomal differences affect how muscle cells respond to testosterone.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Good communication helps predict successful aging in older Indonesians.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.